Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Other neoplasm 1

Conditions

Stomach Neoplasms 19Colorectal Neoplasms 16Esophageal Neoplasms 13Barrett Esophagus 8Colonic Neoplasms 7Rectal Neoplasms 6Gastrointestinal Neoplasms 6Colonic Polyps 6Duodenal Neoplasms 3Adenocarcinoma Of Esophagus 3Rectal Neuroendocrine Tumors 2Precancerous Conditions 2Neoplasms 2Hemorrhage 2Gastric GIST 2Esophageal Squamous Cell Carcinoma 2Adenoma 2Submucosal Tumor of Stomach 1Small Size Gastrointestinal Stromal Tumors 1Polyps 1Polyposis, Gastric 1Personal Satisfaction 1Pathological Conditions, Anatomical 1Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Margins of Excision 1Locally Advanced Rectal Cancer (LARC) 1Leiomyoma 1Intestinal Polyps 1

Interventions

Fluorouracil 67Radiotherapy 53Cisplatin 52Oxaliplatin 47Leucovorin 37Paclitaxel 36Irinotecan 27Docetaxel 23Capecitabine 20Nivolumab 17Carboplatin 16pembrolizumab 15Radiation 15Neoadjuvant Therapy 15Surgical Procedures, Operative 12Cetuximab 12durvalumab 9Drug Therapy 9Biopsy 9Taxes 8Folfox protocol 8Chemotherapy, Adjuvant 8Trastuzumab 7Magnetic Resonance Spectroscopy 7Gefitinib 7Endoscopy 7tremelimumab 6Specimen Handling 6Endoscopy, Digestive System 6Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Endoscopic Mucosal Resection × Gastrointestinal × Clear all
NCT04929392 2025-09-04

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
3 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT02583087 2017-08-28

ESTEBAN

Hôpital Cochin

Unknown
150 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms

NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡